大動脈瘤の市場規模、シェア、成長分析、タイプ別、治療法別、製品別、最終用途別、地域別 - 産業予測、2025-2032年

大動脈瘤（AA）の世界市場規模は2023年に41億2,000万米ドルと評価され、2024年の45億2,000万米ドルから2032年には95億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.8％で成長する見通しです。

市場力学は、高齢化人口の増加と動脈硬化の有病率の上昇、特に心血管疾患の罹患率の増加と不健康なライフスタイルの選択によって大きく影響を受けています。米国だけでも、高齢者人口が現在の5,400万人から2040年には8,080万人、2060年には9,470万人に増加し、大動脈瘤治療の患者層が拡大すると予想されています。医療保険償還に関する有利な規制や、ステントグラフト内挿術（EVAR）などの低侵襲手技に対する需要の急増が、市場の成長をさらに後押ししています。これらの手技には、出血量の減少、切開創の縮小、回復の早さ、治療成績の向上といった利点があり、ますます魅力的なものとなっています。さらに、喫煙は特に高齢者において依然として重大な危険因子であり、大動脈瘤の進行や手術成績に影響を及ぼしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• 特許分析

大動脈瘤市場規模：タイプ別

• 市場概要
• 胸部大動脈瘤（TAA）
• 腹部大動脈瘤（AAA）

大動脈瘤市場規模：治療法別

• 市場概要
• 開腹手術（OSR）
• ステントグラフト内挿術（EVAR）

大動脈瘤市場規模：製品別

• 市場概要
• ステントグラフト
• カテーテル
• その他

大動脈瘤市場規模：最終用途別

• 市場概要
• 病院
• 外来手術センター（ASC）
• その他

大動脈瘤市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（USA）
• W.L. Gore & Associates, Inc.（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• Cardinal Health（USA）
• Endologix, LLC（USA）
• Lombard Medical（UK）
• CryoLife, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（USA）
• Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• Terumo Aortic（UK）
• Biotronik SE & Co. KG（Germany）
• Medtronic Vascular, Inc.（USA）

結論と提言

Global Aortic Aneurysm Market size was valued at USD 4.12 billion in 2023 and is poised to grow from USD 4.52 billion in 2024 to USD 9.56 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

Market dynamics are significantly influenced by the growing aging population and the rising prevalence of atherosclerosis, particularly with an increasing incidence of cardiovascular diseases and unhealthy lifestyle choices. In the U.S. alone, the elderly demographic is expected to rise from 54 million today to 80.8 million by 2040 and 94.7 million by 2060, expanding the patient base for aortic aneurysm (AA) repairs. Favorable health reimbursement regulations and a surge in demand for minimally invasive procedures, such as Endovascular Aneurysm Repair (EVAR), further bolster market growth. These procedures offer advantages such as reduced blood loss, smaller incisions, quicker recovery, and improved outcomes, making them increasingly attractive. Additionally, smoking remains a significant risk factor, especially in older adults, affecting AA progression and surgical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segments Analysis

Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is primarily driven by the escalating number of aortic aneurysm cases, especially among the elderly demographic. This rise can be attributed to various risk factors, including hypertension, smoking, and atherosclerosis, which collectively elevate the occurrence of these conditions. As the prevalence of aortic aneurysms continues to grow, there is an urgent demand for advanced diagnostic tools and effective treatment options to manage and address these life-threatening issues. Consequently, the increasing awareness and need for improved healthcare solutions in this area are significantly propelling the market forward.

Restraints in the Global Aortic Aneurysm Market

One of the primary challenges facing the global aortic aneurysm market is the prevailing lack of awareness regarding the condition among both the general public and healthcare professionals. This widespread unawareness can lead to underdiagnosis, which in turn results in delayed treatment and, ultimately, unfavorable patient outcomes. Such issues not only compromise the health of individuals affected by aortic aneurysms but also significantly impede the overall growth of the market. Addressing this knowledge gap is essential for improving diagnosis rates and treatment efficacy, thereby fostering a more robust market environment.

Market Trends of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is witnessing significant growth, driven by advancements in minimally invasive surgical techniques, increasing awareness of vascular diseases, and a rising geriatric population susceptible to aortic aneurysms. The development and adoption of innovative medical devices, such as endovascular stent grafts, along with improvements in diagnostic imaging technologies, are propelling market expansion. Additionally, an increasing focus on research and development activities to enhance patient outcomes is contributing to market dynamics. This trend is further supported by the growing prevalence of risk factors such as hypertension and smoking, underscoring the urgency for effective treatment options in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Aortic Aneurysm Market Size by Type & CAGR (2025-2032)

• Market Overview
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market Size by Product & CAGR (2025-2032)

• Market Overview
• Stent Grafts
• Catheters
• Others

Global Aortic Aneurysm Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Global Aortic Aneurysm Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Product, End-Use)
  • US
  • Canada
• Europe (Type, Treatment, Product, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Product, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Product, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Product, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W.L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Aortic (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations